Skip to main content
. 2020 Aug 17;27(1):1231–1235. doi: 10.1080/10717544.2020.1790692

Figure 5.

Figure 5.

Fractionation of clinical protamine. (A) Visualization of the clinical protamine fractions on polyacrylamide gel. Among the 24 fractions collected, proteins were visible in fractions 2–15. (B) Transfection efficiency of nanoparticles formulated using the clinical protamine (‘clinical’ ) or each Sephadex fraction mixed with mRNA. HEK cells were incubated with nanoparticles (0.5 µg of mRNA and 1.5 µg of protamine) formed from the fractions (90 µg/ml) mixed with mRNA (30 µg/ml). After 18 h of incubation, the luminescence was measured. Data represent triplicate mean values; error bars: SD.